Indiana Substitution Legislation Headed to Governor

In Indiana, Senate Bill 262, has successfully moved through both chambers of the legislature with a strong vote of 92-5 in the State House.    The legislation will now move to Governor Pence where it is hoped to quickly be considered.

ASBM has written Governor Pence in strong support of the enactment of this legislation stating, “We believe that when interchangeable biosimilar products are substituted, communication among patients, pharmacists, and health care providers is essential to patient care and, therefore, we fully support SB 262 and are concerned that patient safety will be compromised if this legislation is not enacted.”

To view legislation click here.

To view ASBM letter to Governor Pence click here.